An 11-year-old child who was born and raised in the United States requires tuberculosis screening due to a household contact with active disease. The child has no history of BCG vaccination. An INF-γ release assay (IGRA) is performed instead of a tuberculin skin test (TST). What is a key advantage of IGRA over TST in this particular patient?